We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Finds Objectionable Conditions at Clinical Trial Site
FDA Finds Objectionable Conditions at Clinical Trial Site
April 8, 2005
The FDA has issued a warning letter to the Weil Foot & Ankle Institute, headquartered in Des Plaines, Ill., citing objectionable conditions found at the institute’s clinical site during a recent inspection.